Evidence map›Paper›PMID 41861915›Full record

ArticleJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance

Myocardial T2 mapping using wideband T2 preparation gradient echo readout for patients with implantable cardiac devices at 1.5T.

Pauline Gut, Hubert Cochet, Thomas Küstner, Guido Caluori, Konstantinos Vlachos, Panagiotis Antiochos, Ambra Masi, Juerg Schwitter, Frederic Sacher, Pierre Jaïs and 2 more

Abstract read
In one paragraph

Article in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pauline GutIHU LIRYC, Heart Rhythm Disease Institute, UniversitÉ de Bordeaux - INSERM U1045, Avenue du Haut LÉvÊque, Pessac, France; Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Faculty of Biology and Medicine, University of Lausanne, UniL, Switzerland.
Hubert CochetIHU LIRYC, Heart Rhythm Disease Institute, UniversitÉ de Bordeaux - INSERM U1045, Avenue du Haut LÉvÊque, Pessac, France; Department of Cardiovascular Imaging, HÔpital Cardiologique du Haut-LÉvÊque, CHU de Bordeaux, Avenue de Magellan, Pessac, France.
Thomas KüstnerDepartment of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany.
Guido CaluoriIHU LIRYC, Heart Rhythm Disease Institute, UniversitÉ de Bordeaux - INSERM U1045, Avenue du Haut LÉvÊque, Pessac, France.
Konstantinos VlachosIHU LIRYC, Heart Rhythm Disease Institute, UniversitÉ de Bordeaux - INSERM U1045, Avenue du Haut LÉvÊque, Pessac, France.
Panagiotis AntiochosCardiovascular Department, Cardiology Division, University Hospital of Lausanne (CHUV), Switzerland.
Ambra MasiCardiovascular Department, Cardiology Division, University Hospital of Lausanne (CHUV), Switzerland.
Juerg SchwitterFaculty of Biology and Medicine, University of Lausanne, UniL, Switzerland; Cardiovascular Department, Cardiology Division, University Hospital of Lausanne (CHUV), Switzerland; Director of the CMR Center and the Interventional MRI Center of the University Hospital Lausanne, CHUV, Switzerland.
Frederic SacherIHU LIRYC, Heart Rhythm Disease Institute, UniversitÉ de Bordeaux - INSERM U1045, Avenue du Haut LÉvÊque, Pessac, France; Department of Cardiac Pacing and Electrophysiology, HÔpital Cardiologique du Haut-LÉvÊque, CHU de Bordeaux, Avenue de Magellan, Pessac, France.
Pierre JaïsIHU LIRYC, Heart Rhythm Disease Institute, UniversitÉ de Bordeaux - INSERM U1045, Avenue du Haut LÉvÊque, Pessac, France; Department of Cardiac Pacing and Electrophysiology, HÔpital Cardiologique du Haut-LÉvÊque, CHU de Bordeaux, Avenue de Magellan, Pessac, France.
Matthias StuberIHU LIRYC, Heart Rhythm Disease Institute, UniversitÉ de Bordeaux - INSERM U1045, Avenue du Haut LÉvÊque, Pessac, France; Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Faculty of Biology and Medicine, University of Lausanne, UniL, Switzerland; CIBM Center for Biomedical Imaging, Lausanne, Switzerland.
Aurélien BustinIHU LIRYC, Heart Rhythm Disease Institute, UniversitÉ de Bordeaux - INSERM U1045, Avenue du Haut LÉvÊque, Pessac, France; Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Department of Cardiovascular Imaging, HÔpital Cardiologique du Haut-LÉvÊque, CHU de Bordeaux, Avenue de Magellan, Pessac, France. Electronic address: aurelien.bustin@ihu-liryc.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial T2 mapping enables non-invasive assessment of inflammation and edema. However, in patients with implantable cardiac devices, such as pacemakers or defibrillators (ICDs), off-resonance effects often cause severe image artifacts and inaccurate T2 values. PURPOSE: The aim of this study was to develop and evaluate a wideband T2-prepared gradient-echo (GRE) myocardial T2 mapping sequence combined with an advanced patch-based denoising approach, designed to reduce artifacts and improve image quality in device-implanted patients at 1.5T.

methodsA T2 preparation with wideband adiabatic refocusing pulses (5.0 kHz bandwidth) was integrated into a breath-held 2D GRE T2 mapping sequence (TE = 0/27/55ms). Patch-based denoising was applied after image reconstruction. The sequence was tested in a phantom, 8 healthy volunteers with and without ICDs placed on their chests, 13 patients without devices, 7 patients with ICDs or pacemakers, and 1 sheep scanned before and after induced myocardial infarction with and without external ICD. The proposed sequence was compared against reference conventional GRE and balanced steady-state free-precession (bSSFP) T2 mapping. Patch-based denoising was optimized in patients without devices and impact on T2 precision and accuracy was assessed. Phantom studies included Bland-Altman and correlation analyses between the sequences. In-vivo performance was assessed through global and segmental T2 quantification, coefficient of variation (COV), artifact scoring, and edema detection. ANOVA with Bonferroni correction and pairwise testing were used for statistical comparisons.

resultsIn subjects without devices, wideband and conventional GRE T2 mapping yielded comparable T2 values (P = 0.60). With ICDs, conventional GRE T2 mapping underestimated global T2 by 16% (P<0.001) and increased segmental COV up to 30%. In contrast, wideband GRE T2 mapping provided accurate T2 values (P = 0.56) and preserved edema detection, showing relative T2 elevations of 44% comparable to bSSFP. Patch-based denoising significantly improved precision (P = 0.006) without biasing mean values (P = 0.999). Results were consistent across phantom, volunteer, patient, and animal experiments, including animal ex-vivo histology confirmation.

conclusionWideband GRE T2 mapping substantially reduced device-related artifacts, provided accurate T2 values, and allowed edema detection, offering a clinically feasible solution for patients with cardiac implants in this initial study.

Indexed as

Defibrillators, ImplantableEdema, CardiacImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMyocardial InfarctionMyocardiumPacemaker, ArtificialAdultAgedAnimalsArtifactsCase-Control StudiesDisease Models, AnimalFemaleHumansMaleDenoisingImplantable cardiac devicesImplantable cardioverter defibrillatorMyocardial T2 mappingWideband MRI

Identifiers

PMID41861915
PMCPMC13237538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.